Cargando…
Multiorgan Involvement in COVID-19 and Possible Therapies
In late 2019, China reported cases of respiratory illness in humans, which involved a novel Coronavirus SARS-CoV-2 (also known as 2019-nCoV). The World Health Organization (WHO) termed the disease COVID-19 (i.e., Coronavirus disease 2019). Most of the morbidity and mortality from COVID-19 is largely...
Autores principales: | Sathe, Prachee, Singh, Vijay Sundar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Private Ltd.
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416215/ http://dx.doi.org/10.1055/s-0040-1714151 |
Ejemplares similares
-
Hepatic Amyloidosis With Multiorgan Involvement
por: Duve, Robert J., et al.
Publicado: (2023) -
COVID-19 and Multiorgan Response
por: Zaim, Sevim, et al.
Publicado: (2020) -
COVID-19 vaccination-related small vessel vasculitis with multiorgan involvement
por: Kim, Yunkyung, et al.
Publicado: (2022) -
Mediterranean spotted fever with multiorgan involvement
por: Davis, Kimberly, et al.
Publicado: (2022) -
Hypereosinophilic Syndrome, Multiorgan Involvement and Response to Imatinib
por: Hana, Caroline K, et al.
Publicado: (2020)